Payment overview · 2025
General Payments
$206.11
2 reported records · 2 companies
Healthcare provider profile · identity verified
Sumner R Cullom, M.D.
Allopathic & Osteopathic Physicians|General Practice · OSCEOLA, AR · NPI 1902885015
Verified facts
What the public records show
CMS Open Payments records show Sumner R Cullom, M.D. received $206.11 in general payments during 2025 across 2 reported records.
Novo Nordisk Inc accounted for 54.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 92 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 77 claims for Mounjaro by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Trulicity by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 136 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $112.01 | 54.3% | 1 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $94.10 | 45.7% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $206.11 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Wegovy Normalized: wegovy |
Drug | Novo Nordisk Inc | $112.01 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
92 | 23 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | MOUNJARO open payments reported associated product |
CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455 |
Mounjaro · 2024 Exact normalized brand match · 1 Part D row |
77 | 16 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
11 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
136 | 23 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Clonazepam | Clonazepam | 1068 | 166 |
| Furosemide | Furosemide | 867 | 194 |
| Pantoprazole Sodium | Pantoprazole Sodium | 860 | 184 |
| Lisinopril | Lisinopril | 828 | 153 |
| Amlodipine Besylate | Amlodipine Besylate | 790 | 151 |
| Gabapentin | Gabapentin | 698 | 158 |
| Atorvastatin Calcium | Atorvastatin Calcium | 657 | 125 |
| Meloxicam | Meloxicam | 576 | 120 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 543 | 229 |
| Prednisone | Prednisone | 543 | 284 |
| Allopurinol | Allopurinol | 540 | 97 |
| Potassium Chloride | Potassium Chloride | 520 | 119 |
| Metoprolol Succinate | Metoprolol Succinate | 472 | 97 |
| Omeprazole | Omeprazole | 468 | 103 |
| Clopidogrel | Clopidogrel Bisulfate | 452 | 90 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 406 | 164 |
| Montelukast Sodium | Montelukast Sodium | 400 | 80 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 396 | 76 |
| Metformin Hcl | Metformin Hcl | 388 | 79 |
| Amoxicillin | Amoxicillin | 384 | 241 |
| Metoprolol Tartrate | Metoprolol Tartrate | 379 | 71 |
| Tamsulosin Hcl | Tamsulosin Hcl | 379 | 73 |
| Zolpidem Tartrate | Zolpidem Tartrate | 367 | 67 |
| Diclofenac Sodium | Diclofenac Sodium | 357 | 86 |
| Azithromycin | Azithromycin | 339 | 231 |
| Glipizide Er | Glipizide | 311 | 70 |
| Hydrochlorothiazide | Hydrochlorothiazide | 308 | 69 |
| Carvedilol | Carvedilol | 299 | 63 |
| Citalopram Hbr | Citalopram Hydrobromide | 295 | 55 |
| Levothyroxine Sodium | Levothyroxine Sodium | 256 | 51 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 247 | 57 |
| Losartan Potassium | Losartan Potassium | 238 | 53 |
| Diazepam | Diazepam | 223 | 37 |
| Sertraline Hcl | Sertraline Hcl | 219 | 45 |
| Alprazolam | Alprazolam | 217 | 43 |
| Fenofibrate | Fenofibrate | 215 | 44 |
| Simvastatin | Simvastatin | 214 | 42 |
| Spironolactone | Spironolactone | 211 | 46 |
| Duloxetine Hcl | Duloxetine Hcl | 191 | 37 |
| Glipizide | Glipizide | 191 | 43 |
| Clonidine Hcl | Clonidine Hcl | 188 | 35 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 184 | 54 |
| Trazodone Hcl | Trazodone Hcl | 182 | 30 |
| Estradiol | Estradiol | 177 | 40 |
| Eliquis | Apixaban | 166 | 37 |
| Tizanidine Hcl | Tizanidine Hcl | 160 | 36 |
| Lorazepam | Lorazepam | 150 | 24 |
| Temazepam | Temazepam | 146 | 25 |
| Ibuprofen | Ibuprofen | 136 | 72 |
| Ozempic | Semaglutide | 136 | 23 |
| Pregabalin | Pregabalin | 130 | 24 |
| Quetiapine Fumarate | Quetiapine Fumarate | 130 | 19 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 127 | 28 |
| Meclizine Hcl | Meclizine Hcl | 122 | 56 |
| Warfarin Sodium | Warfarin Sodium | 122 | 21 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 111 | 86 |
| Clindamycin Hcl | Clindamycin Hcl | 109 | 71 |
| Ropinirole Hcl | Ropinirole Hcl | 104 | 21 |
| Pioglitazone Hcl | Pioglitazone Hcl | 101 | 20 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 100 | 18 |
| Celecoxib | Celecoxib | 99 | 17 |
| Atenolol | Atenolol | 93 | 16 |
| Fluticasone Propionate | Fluticasone Propionate | 92 | 21 |
| Jardiance | Empagliflozin | 92 | 23 |
| Tramadol Hcl | Tramadol Hcl | 91 | 41 |
| Indomethacin | Indomethacin | 90 | 45 |
| Ezetimibe | Ezetimibe | 88 | 17 |
| Escitalopram Oxalate | Escitalopram Oxalate | 85 | 16 |
| Linzess | Linaclotide | 85 | 15 |
| Ondansetron Odt | Ondansetron | 85 | 58 |
| Pravastatin Sodium | Pravastatin Sodium | 85 | 21 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 79 | 13 |
| Mounjaro | Tirzepatide | 77 | 16 |
| Fluconazole | Fluconazole | 75 | 39 |
| Fluoxetine Hcl | Fluoxetine Hcl | 75 | 15 |
| Baclofen | Baclofen | 74 | 14 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 72 | 59 |
| Donepezil Hcl | Donepezil Hcl | 70 | 15 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 70 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 70 | 28 |
| Azelastine Hcl | Azelastine Hcl | 69 | 45 |
| Amitriptyline Hcl | Amitriptyline Hcl | 67 | 12 |
| Colchicine | Colchicine | 67 | 23 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 65 | 17 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 65 | 32 |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 64 | 23 |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 64 | 37 |
| Alendronate Sodium | Alendronate Sodium | 63 | 12 |
| Fenofibrate | Fenofibrate,micronized | 60 | 16 |
| Lansoprazole | Lansoprazole | 59 | 11 |
| Hydralazine Hcl | Hydralazine Hcl | 58 | 14 |
| Memantine Hcl | Memantine Hcl | 58 | 15 |
| Metolazone | Metolazone | 58 | 13 |
| Sucralfate | Sucralfate | 58 | 22 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 57 | 13 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 56 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 52 | 39 |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 51 | 13 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 51 | 15 |
| Metformin Hcl Er | Metformin Hcl | 49 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 49 | 34 |
| Promethazine Hcl | Promethazine Hcl | 48 | 26 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 47 | 12 |
| Doxycycline Hyclate | Doxycycline Hyclate | 47 | 37 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 47 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 46 | suppressed |
| Naproxen | Naproxen | 46 | 12 |
| Levetiracetam | Levetiracetam | 45 | 11 |
| Methotrexate | Methotrexate Sodium | 45 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 44 | 11 |
| Topiramate | Topiramate | 43 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 42 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 42 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 41 | suppressed |
| Bupropion Xl | Bupropion Hcl | 40 | suppressed |
| Glimepiride | Glimepiride | 40 | suppressed |
| Famotidine | Famotidine | 39 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 39 | 21 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 37 | 14 |
| Fenofibrate | Fenofibrate Nanocrystallized | 36 | suppressed |
| Neomycin-Polymyxin-Hc | Neomycin/Polymyxin B/Hydrocort | 36 | 31 |
| Benazepril Hcl | Benazepril Hcl | 35 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 35 | 13 |
| Gemfibrozil | Gemfibrozil | 34 | suppressed |
| Ramipril | Ramipril | 34 | 11 |
| Farxiga | Dapagliflozin Propanediol | 33 | suppressed |
| Lamotrigine | Lamotrigine | 33 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 33 | suppressed |
| Xarelto | Rivaroxaban | 33 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 32 | suppressed |
| Risperidone | Risperidone | 30 | suppressed |
| Nitroglycerin | Nitroglycerin | 29 | 14 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 28 | suppressed |
| Verapamil Er | Verapamil Hcl | 28 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 27 | 11 |
| Cilostazol | Cilostazol | 27 | suppressed |
| Verapamil Sr | Verapamil Hcl | 27 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 26 | suppressed |
| Levofloxacin | Levofloxacin | 26 | 22 |
| Torsemide | Torsemide | 26 | suppressed |
| Aripiprazole | Aripiprazole | 25 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 25 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 25 | suppressed |
| Neomycin-Polymyxin-Gramicidin | Neomycin/Polymyxn B/Gramicidin | 25 | 22 |
| Bupropion Hcl | Bupropion Hcl | 24 | suppressed |
| Latanoprost | Latanoprost | 24 | suppressed |
| Nifedipine Er | Nifedipine | 24 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 23 | suppressed |
| Nystatin | Nystatin | 23 | 16 |
| Primidone | Primidone | 23 | suppressed |
| Procto-Med Hc | Hydrocortisone | 23 | 13 |
| Propranolol Hcl | Propranolol Hcl | 23 | suppressed |
| Sotalol | Sotalol Hcl | 23 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 23 | suppressed |
| Chlorthalidone | Chlorthalidone | 22 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 22 | suppressed |
| Mirtazapine | Mirtazapine | 22 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 22 | suppressed |
| Bumetanide | Bumetanide | 21 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 21 | suppressed |
| Finasteride | Finasteride | 21 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 21 | suppressed |
| Ketoconazole | Ketoconazole | 21 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 21 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 20 | 15 |
| Cephalexin | Cephalexin | 20 | 18 |
| Febuxostat | Febuxostat | 20 | suppressed |
| Irbesartan | Irbesartan | 20 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 19 | suppressed |
| Digoxin | Digoxin | 19 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 19 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 19 | suppressed |
| Klor-Con M20 | Potassium Chloride | 19 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 19 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 19 | 12 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 19 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 18 | suppressed |
| Folic Acid | Folic Acid | 18 | suppressed |
| Januvia | Sitagliptin Phosphate | 18 | suppressed |
| Lovastatin | Lovastatin | 18 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 18 | suppressed |
| Hydrocortisone | Hydrocortisone | 17 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 17 | suppressed |
| Roflumilast | Roflumilast | 17 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 16 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 16 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 16 | suppressed |
| Mupirocin | Mupirocin | 16 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 15 | suppressed |
| Cholestyramine Light | Cholestyramine | 15 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 15 | 11 |
| Novolin R | Insulin Regular, Human | 15 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 15 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 15 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 14 | suppressed |
| Calcitriol | Calcitriol | 14 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 14 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 14 | suppressed |
| Prasugrel Hcl | Prasugrel Hcl | 14 | suppressed |
| Terbutaline Sulfate | Terbutaline Sulfate | 14 | suppressed |
| Terconazole | Terconazole | 14 | suppressed |
| Valsartan | Valsartan | 14 | suppressed |
| Entresto | Sacubitril/Valsartan | 13 | suppressed |
| Ranolazine Er | Ranolazine | 13 | suppressed |
| Timolol Maleate | Timolol Maleate | 13 | suppressed |
| Trandolapril | Trandolapril | 13 | suppressed |
| Anastrozole | Anastrozole | 12 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 12 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 12 | suppressed |
| Indapamide | Indapamide | 12 | suppressed |
| Neomycin-Polymyxin-Hydrocort | Neomycin/Polymyxin B/Hydrocort | 12 | 12 |
| Paroxetine Hcl | Paroxetine Hcl | 12 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 12 | suppressed |
| Tradjenta | Linagliptin | 12 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Xifaxan | Rifaximin | 12 | suppressed |
| Zafirlukast | Zafirlukast | 12 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 11 | suppressed |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 11 | suppressed |
| Trulicity | Dulaglutide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $206.11 · 2 records | Novo Nordisk Inc | Wegovy | 4 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error